Patents by Inventor Jack Aurora

Jack Aurora has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230338320
    Abstract: The invention relates to a pharmaceutical composition in the form of an oral film comprising levothyroxine and a film forming polymer. The oral film can be of various types such as and including a mouth dissolving or soluble film, non-mucoadhesive film, fast disintegrating film, buccal film, mucoadhesive film, sublingual film, edible film or wafer. The invention also relates to a process of preparation of such oral film compositions.
    Type: Application
    Filed: November 23, 2020
    Publication date: October 26, 2023
    Applicant: Wockhardt Limited
    Inventors: Jack Aurora, Moinuddin Rashid Syed, Rajendra Gawali
  • Publication number: 20100204292
    Abstract: A pharmaceutical composition comprising i) an intra-granular fraction containing a pharmaceutically acceptable active component and a first excipient and ii) an extra-granular fraction containing a second excipient. The pharmaceutical composition is characterized by being substantially surfactant-free and by exhibiting a rapid-dissolution profile.
    Type: Application
    Filed: August 17, 2007
    Publication date: August 12, 2010
    Inventors: Jack Aurora, Naresh Talwar, Jyoti Missra, Kiran Shankar Lagu
  • Publication number: 20070224266
    Abstract: A pharmaceutical composition wherein the pharmaceutically active ingredient (i.e. drug component) comprises Descarbonylethoxyloratadine and which further comprises an acidic element and a pharmaceutically acceptable stabilizer element.
    Type: Application
    Filed: December 21, 2006
    Publication date: September 27, 2007
    Inventors: Jack Aurora, Brijesh Kumar Dave
  • Publication number: 20070092565
    Abstract: A gastric retention drug delivery system (i.e. a controlled release drug dosage form) formulated so as to promote retention of the dosage form in the upper gastrointestinal tract and in particular the stomach.
    Type: Application
    Filed: October 25, 2005
    Publication date: April 26, 2007
    Inventors: Jack Aurora, Vinayak Sant
  • Publication number: 20050118262
    Abstract: The present invention discloses a controlled release formulation suitable for oral administration comprising N6-cyclopentyl-5?-(N-ethyl)carboxamidoadenosine or a pharmaceutically acceptable salt or ester thereof incorporated in a controlled release matrix. The controlled release formulation of the invention is especially suitable for treating heart rhythm disturbances in a mammal.
    Type: Application
    Filed: September 17, 2004
    Publication date: June 2, 2005
    Inventors: Jack Aurora, Manmohan Gill, Kenneth Ong